Could a second eye drop help kids with stubborn lazy eye see better?
NCT ID NCT07554131
First seen May 04, 2026 · Last updated Jun 08, 2026 · Updated 10 times
Summary
This study tests whether adding echothiophate eye drops to standard atropine treatment can improve vision in children aged 3 to 17 with refractory amblyopia (lazy eye that hasn't improved with usual care). Twenty participants will use atropine in the stronger eye for 4 weeks; if no improvement, they add echothiophate to the weaker eye for 8 more weeks. The goal is to see if this combination can boost eyesight, depth perception, and motion detection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY AMBLYOPIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dean McGee Eye Institute
Oklahoma City, Oklahoma, 73104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.